MiR-34a, as a downstream target of tumor suppressor p53, can function as a link between p53 signaling and the cell cycle regulation by targeting cyclin D1, CDK4, and CDK2 in HCC [47]. The gene discussed is TP53; the disease is hepatocellular carcinoma.